J B Chemicals & Pharmaceuticals Ltd share price logo

J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM)

₹1790.50.93%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Analyst Rating

based on 12 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 12 analysts offering long term price targets for J B Chemicals & Pharmaceuticals Ltd. An average target of ₹1975.42

Source: S&P Global Market Intelligence

J B Chemicals & Pharmaceuticals Ltd Share analysis

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹1,772.2
    ₹1,813.8
  • 52 Week's Low

    52 Week's High

    ₹1,183.8
    ₹1,940
1 Month Return-0.89 %
3 Month Return+ 0.14 %
1 Year Return+ 43.09 %
Previous Close₹1,807.35
Open₹1,813.80
Volume97.03K
Upper Circuit-
Lower Circuit-
Market Cap₹28,052.43Cr

Key Statistics

P/E Ratio50.08
PEG Ratio5.41
Market Cap₹28,052.43 Cr
P/B Ratio6.24
EPS12.085

Mutual Fund Holdings

Funds HoldingsPrev. 6M
Axis Small Cap Fund Direct GrowthAxis Small Cap Fund Direct Growth1.9%
Kotak Emerging Equity Scheme Direct GrowthKotak Emerging Equity Scheme Direct Growth0.83%
Franklin India Smaller Companies Fund Direct GrowthFranklin India Smaller Companies Fund Direct Growth1.81%
Nippon India Pharma Fund - Direct Plan - Growth PlanNippon India Pharma Fund - Direct Plan - Growth Plan3.03%
Nippon India Multi Cap Fund - Direct Plan - GrowthNippon India Multi Cap Fund - Direct Plan - Growth0.48%

Company Information

J B Chemicals Pharmaceuticals, founded in 1976 in Maharastra, is a global player in pharmaceutical manufacturing. It manufactures and markets a wide range of pharmaceutical formulations, herbal remedies, APIs, and agro-based products. It has subsidiaries in India and other countries and has been awarded the Certificate of Suitability to European Pharmacopoeia Monograph for Nifedipine EP from the European Directorate for Quality Medicines. It launched new products in the global market to expand its product portfolio and received approval from TGA Australia, USFDA, MCC South Africa, INVIMA Colombia, and MHRA UK. The company received the 'Most Trustworthy European Brand' by Readers Digest in cold and cough segment for the fourth consecutive year in 2003-04. It diverted into the contrast media products market during 2004-05 and entered agreements with PharmaaCare Pharmaceuticals and Ranbaxy Group for developing and marketing niche products in respective markets. It has undergone several mergers and diversifications in-order to increase its product range and profitability. More recently, it acquired a portfolio of brands from Sanzyme Private Limited and Azmarda brand from Novartis AG Switzerland. Thus, J B Chemicals Pharmaceuticals is well positioned to grow and progress further in the global pharmaceutical market.

Share Price: ₹1790.50 per share as on 19 Jul, 2024 04:01 PM
Market Capitalisation: ₹28,052.43Cr as of today
Revenue: ₹861.73Cr as on March 2024 (Q1 24)
Net Profit: ₹126.16Cr as on March 2024 (Q1 24)
Listing date: 02 Feb, 1995
Chairperson Name: Ranjit Shahani.
OrganisationJ B Chemicals & Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for J B Chemicals & Pharmaceuticals Ltd

  • JB Chemicals & Pharma Receives Strong Buy Recommendation - 02 Jul, 2024

    Kotak Securities has initiated coverage of JB Chemicals & Pharma with a strong buy recommendation and a target price of Rs 2,025, suggesting a potential 15% upside. The company's diverse portfolio, niche presence in contract manufacturing, and measured expansion strategy are expected to drive growth. Despite the risk of NMDA contamination impacting the Rantac franchise, analysts anticipate healthy return ratios and cash flow profiles. At present, shares of JB Chemicals & Pharma were trading at Rs 1,796.45.

  • Kotak Initiates Coverage on JB Chemicals & Pharma with Buy Rating - 01 Jul, 2024

    Shares of JB Chemicals & Pharmaceuticals surge nearly 9% after Kotak Institutional Equities initiates coverage with a buy rating and target price of Rs 2,025. The brokerage forecasts a 14% CAGR in sales and a 17% CAGR in EBITDA for the company over fiscal 2024 to 2027.

  • KKR Emerges as Front-Runner to Buy Majority Stake in JB Chemicals & Pharmaceuticals - 28 Jun, 2024

    US private equity firm KKR is set to acquire a 51% stake in JB Chemicals and Pharmaceuticals for ₹2,500-₹3,000 crore in an all-cash deal that includes an open offer. The deal is expected to be finalized within a month.

  • J B Chemicals & Pharmaceuticals Ltd Drops for Fifth Straight Session - 26 Jun, 2024

    J B Chemicals & Pharmaceuticals Ltd drops 0.58% to Rs 1734.3 on NSE, easing around 2.68% in last one month with a PE of 49.8 based on TTM earnings ending March 24. Meanwhile, Nifty Pharma index has increased around 2.28% in the same period.

  • J B Chemicals & Pharmaceuticals Ltd Up for Fifth Straight Session - 13 Jun, 2024

    J B Chemicals & Pharmaceuticals Ltd stock is up 0.35% on the day and has gained 74.54% in the last year, outperforming NIFTY and Nifty Pharma. The PE of the stock is 53.97 based on TTM earnings ending March 24.

Insights on J B Chemicals & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 10.35% to 11.05% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 851.86 Cr → 878.36 Cr (in ₹), with an average increase of 3.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, JBCHEPHARM stock has moved up by 0.3%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 53.83% to 53.78% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 150.59 Cr → 126.16 Cr (in ₹), with an average decrease of 8.4% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 15.66% to 15.45% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 17.28% to 16.78% in Mar 2024 quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹861.73Cr
↑2.04%
Net Income
₹126.16Cr
↓5.55%
Net Profit Margin
14.64%
↓7.46%
2023Y/Y Change
Revenue
₹3,149.28Cr
↑29.91%
Net Income
₹410.01Cr
↑6.21%
Net Profit Margin
13.02%
↓18.22%
Value in ₹ crore
2023Y/Y Change
Total Assets
₹3,477.67Cr
↑36.57%
Total Liabilities
₹1,035.18Cr
↑133.79%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹628.64Cr
↑327.36%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
53.78%
0.00
Foreign Institutions
11.05%
0.00
Mutual Funds
15.45%
0.00
Retail Investors
16.78%
0.00
Others
2.94%
0.00

Key Indicators

J B Chemicals & Pharmaceuticals Ltd Valuation

J B Chemicals & Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (10.61x)

October 24, 2019

Today (50.08x)

July 19, 2024

Industry (57.38x)

July 19, 2024

Highest (54.22x)

February 7, 2024

LowHigh

Earnings and Dividends

  • J B Chemicals & Pharmaceuticals Ltd Earnings Results

    J B Chemicals & Pharmaceuticals Ltd’s net profit jumped 43.97% since last year same period to ₹126.16Cr in the Q4 2023-2024. On a quarterly growth basis, J B Chemicals & Pharmaceuticals Ltd has generated -5.55% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • J B Chemicals & Pharmaceuticals Ltd Dividends February,2024

    In the quarter ending December 2023, J B Chemicals & Pharmaceuticals Ltd has declared dividend of ₹5.50 - translating a dividend yield of 1.30%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

J B Chemicals & Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy J B Chemicals & Pharmaceuticals Ltd shares.

J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) share price today is ₹1790.5

J B Chemicals & Pharmaceuticals Ltd is listed on NSE

J B Chemicals & Pharmaceuticals Ltd is listed on BSE

  • Today’s highest price of J B Chemicals & Pharmaceuticals Ltd is ₹1813.8.
  • Today’s lowest price of J B Chemicals & Pharmaceuticals Ltd is ₹1772.2.

PE Ratio of J B Chemicals & Pharmaceuticals Ltd is 50.08

PE ratio = J B Chemicals & Pharmaceuticals Ltd Market price per share / J B Chemicals & Pharmaceuticals Ltd Earnings per share

Today’s traded volume of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is 97.03K.

Today’s market capitalisation of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is ₹28052.43Cr.

J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARMPrice
52 Week High
₹1940
52 Week Low
₹1183.8

J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) share price is ₹1790.5. It is down -7.71% from its 52 Week High price of ₹1940

J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) share price is ₹1790.5. It is up 51.25% from its 52 Week Low price of ₹1183.8

J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARMReturns
1 Day Returns
-16.85%
1 Month Returns
-0.89%
3 Month Returns
0.14%
1 Year Returns
43.09%